The Global Institute for Novel Nicotine (GINN) has released its Member Code of Practice (CoP) to establish a comprehensive framework for the manufacturing and labelling of novel nicotine products. With regulatory landscapes evolving, GINN aims to ensure product safety, quality, and ethical practices, setting a standard for responsible nicotine innovation. A Framework for Responsible Manufacturing…
A BBC News investigation has shed light on the growing issue of illicit nicotine pouches in the UK, revealing the extent of unregulated sales and their impact on public health. The report highlights how some high-nicotine, unregulated pouches are being sold without proper safety labeling, age restrictions, or marketing controls. This raises concerns about youth…
The Global Institute for Novel Nicotine (GINN) is proud to champion oral health as a vital component of tobacco harm reduction. Through evidence-based research and actionable guidance, GINN is committed to reducing the burden of tobacco-related oral diseases and fostering healthier outcomes for communities worldwide. A Science-Driven Approach to Oral Health Tobacco use has long…
In Finland, nicotine pouches are subject to a specific taxation system that is tied to their strength. The tax is calculated based on the nicotine content per pouch, meaning that higher-strength pouches incur higher taxes. This system aims to discourage the use of high-nicotine products, promoting public health by making them less financially attractive. It’s…
The illicit nicotine pouch market is expanding rapidly, echoing the challenges faced during the early days of the unregulated e-vapor market. Without decisive action, this unregulated sector poses risks to public health, undermines harm reduction efforts, and creates an unfair playing field for compliant manufacturers. Understanding the root causes and addressing the issue with a…
A recent revelation from a leaked confidential document distributed by the European Commission’s consultant has sent ripples across the nicotine pouch industry. The document reportedly recommends a complete ban on nicotine pouches within the European Union, citing concerns over youth appeal, insufficient regulation, and perceived risks. This proposal has ignited significant debate among public health…
Norway is witnessing a profound shift in its approach to tobacco use, driven by consumer preferences and product innovation. The rise of snus, a smokeless, tobacco-containing product, has significantly reshaped the country’s public health landscape. This consumer-led movement demonstrates the transformative potential of harm reduction strategies and highlights the importance of providing safer alternatives for…
The rise of modern oral nicotine products, such as nicotine pouches and lozenges, represents a significant shift in the tobacco harm reduction landscape. These tobacco-free alternatives are increasingly being adopted by adult consumers seeking safer nicotine delivery options. However, with their rapid growth, global regulatory bodies face the challenge of establishing robust frameworks that balance…
We are thrilled to announce the appointment of Phil Hudson as the newest member of the GINN team. Phil will spearhead membership and outreach initiatives across the UK and European markets, bringing a wealth of experience and insight to our mission of advancing tobacco harm reduction and fostering innovation in the novel nicotine industry. A…
The U.S. Food and Drug Administration (FDA) has taken a landmark step in tobacco harm reduction by authorizing the marketing of 20 ZYN nicotine pouch products. This authorization, granted under the Premarket Tobacco Product Application (PMTA) process, establishes a clear regulatory pathway for nicotine pouches, reinforcing their role as a viable alternative for adult smokers…